Lucia Nichelli

9PUBLICATIONS
49CO-AUTHORS
Gene and molecular therapyCancer diagnosisPredictive and prognostic markersMedical infection agents (incl. prions)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 02, 2026
18F-DOPA-PET and Advanced MRI Improve Treatment Response Assessment in IDH1/2-Mutant Gliomas Treated with IDH Inhibitors.

Diego Prost, Lucia Nichelli, Laura Rozenblum

|Sep 19, 2025
Automatic Segmentation of Primary Central Nervous System Lymphoma at Clinical Routine Postcontrast T1-weighted MRI.

Guanghui Fu, Lucia Nichelli, Darío Herrán de la Gala

|Apr 14, 2025
Fluid-Suppressed Amide Proton Transfer-Weighted Imaging Outperforms Leakage-Corrected Dynamic Susceptibility Contrast Perfusion in Distinguishing Progression from Radionecrosis in Brain Metastases.

Lucia Nichelli, Stefano Casagranda, Ottavia Dipasquale

|Mar 11, 2025
The Mickey Mouse's hand sign in brain MRI points out multinodular and vacuolating neuronal tumors in mesial temporal lobe structures.

Valerio Frazzini, Bertrand Mathon, Natalia Shor

|Oct 02, 2024
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma.

Salah Eddine O Kacimi, Caroline Dehais, Loïc Feuvret

|Aug 08, 2024
Epilepsy in Patients With Primary CNS Lymphoma: Prevalence, Risk Factors, and Prognostic Significance.

Oumaima Aboubakr, Caroline Houillier, Agusti Alentorn

Pageof 2

Frequent Collaborators

5 joint publications

Bertrand Mathon

4 joint publications

Ahmed Idbaih

3 joint publications

Franck Bielle

2 joint publications

Alessia Pellerino